YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2006-06-20
Last Posted Date
2015-01-29
Lead Sponsor
Yale University
Target Recruit Count
16
Registration Number
NCT00338494
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2006-06-15
Last Posted Date
2014-01-14
Lead Sponsor
Yale University
Target Recruit Count
23
Registration Number
NCT00337376
Locations
🇺🇸

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven, Connecticut, United States

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

First Posted Date
2006-06-12
Last Posted Date
2021-08-13
Lead Sponsor
Yale University
Target Recruit Count
26
Registration Number
NCT00335829
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Nicotinic Receptor Augmentation of SSRI Antidepressants

Phase 2
Completed
Conditions
First Posted Date
2006-04-27
Last Posted Date
2007-04-19
Lead Sponsor
Yale University
Target Recruit Count
60
Registration Number
NCT00319319
Locations
🇺🇸

Connecticut Mental Health Center, New Haven, Connecticut, United States

Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers

First Posted Date
2006-04-27
Last Posted Date
2020-04-09
Lead Sponsor
Yale University
Target Recruit Count
47
Registration Number
NCT00319436
Locations
🇺🇸

The APT Foundation, New Haven, Connecticut, United States

Relational Parenting Group for Opioid-addicted Mothers

Phase 2
Completed
Conditions
First Posted Date
2006-04-27
Last Posted Date
2020-03-31
Lead Sponsor
Yale University
Target Recruit Count
120
Registration Number
NCT00319241
Locations
🇺🇸

The APT Foundation, New Haven, Connecticut, United States

Buprenorphine and Integrated HIV Care

First Posted Date
2006-04-24
Last Posted Date
2020-04-03
Lead Sponsor
Yale University
Target Recruit Count
52
Registration Number
NCT00317460
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Specialized Treatment Early in Psychosis (STEP)

First Posted Date
2006-03-31
Last Posted Date
2017-02-08
Lead Sponsor
Yale University
Target Recruit Count
120
Registration Number
NCT00309452
Locations
🇺🇸

Connecticut Mental Health Center, New Haven, Connecticut, United States

Transcranial Magnetic Stimulation for "Voices"

First Posted Date
2006-03-30
Last Posted Date
2020-04-02
Lead Sponsor
Yale University
Target Recruit Count
85
Registration Number
NCT00308997
Locations
🇺🇸

Yale Psychiatric Research, New Haven, Connecticut, United States

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

First Posted Date
2006-03-17
Last Posted Date
2018-01-17
Lead Sponsor
Yale University
Target Recruit Count
31
Registration Number
NCT00303888
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath